In Italy during 1995-2004, no significant difference was observed in the incidence rate of acute hepatitis B virus infection in the general population and in healthcare workers, with a downward trend noted in both groups. In contrast, the incidence rate of acute hepatitis C virus infection was significantly higher in healthcare workers than in the general population.
In Italy, despite the strong recommendation since 1985 for healthcare workers (HCWs) to receive the hepatitis B virus (HBV) vaccine , the incidence of hepatitis B in HCWs continued to be higher than that in the general population during 1986-1991, 1 likely reflecting poor vaccination coverage. 2 Hepatitis C virus (HCV) is less infective than HBV. 3 Studies published between 1992 and 2002 involving more than 11,000 HCV-exposed HCWs in 6 countries indicate that the average rate of HCV transmission after a single needlestick exposure is 0.5%. 4 According to the Studio Italiano Rischio Occupazionale da HIV, a nationwide study on the occupational risk of acquiring human immunodeficiency virus (HIV) in Italy, the largest and most standardized study in the world, since 1995 there have been 3,795 exposures to anti-HCV-positive patients and a transmission rate as low as 0.4%. This rate increases to 0.9% in exposures with large inocula (eg, from hollow needles full of blood), whereas it is 0.3% for conjunctival exposure. 5 Similar to hepatitis B, the incidence of acute hepatitis C in Italy during 1991-1994 was significantly higher in HCWs than in the general population. 6 The Sistema Epidemiologico Integrato dell'Epatite Virale Acuta (SEIEVA) is Italy's national surveillance system for acute viral hepatitis, which has been operating since 1985. 7 Using SEIEVA data, we evaluated the incidence trends of acute hepatitis B and hepatitis C in HCWs and compared the incidence of these 2 infections in HCWs and members of the general population of the same age during 1995-2004. The SEIEVA data also served as the basis for the previously performed evaluations. 2, 6 methods SEIEVA was established in 1985, and as of 1997, it contained data on approximately 57% of the Italian population. A description of the system has been published previously. 8 The case definition for acute hepatitis was based on clinical, biochemical, and serological criteria. The clinical and biochemical criteria were an acute illness compatible with hepatitis and alanine aminotransferase levels greater than 2.5 times the normal upper limit. The criteria used to distinguish the different types of acute viral hepatitis were as follows. Acute hepatitis A virus (HAV) infection was defined by serological test results positive for immunoglobulin (Ig) M anti-HAV, regardless of HBV surface antigen status. Acute hepatitis B was defined by serological test results positive for IgM anti-HBV core and negative for IgM anti-HAV (or not performed for IgM anti-HAV). Acute hepatitis C was defined by serological test results that were negative for IgM anti-HAV and IgM anti-HBV core and positive for anti-HCV, regardless of HBV surface antigen status. Assays of hepatitis markers were undertaken in different laboratories using standardized methods. Jaundice was defined on the basis of clinical records. No changes were made in the notification system during the study period. Most individuals with ascertained or suspected acute hepatitis were admitted to the hospital, and local health units were notified of nearly all hospitalized patients.
Statistical analysis was conducted on data for SEIEVA's 18-to 65-year-old population. The incidence rates by year were calculated using as the denominator the population (not HCWs) residing in health districts that were participating in SEIEVA at various time points. In Italy, the total number of HCWs is 670,000. Based on the population covered by SEIEVA, we calculated the number of HCWs surveyed by SEIEVA during 1995-2004; the age of the HCWs ranged from 18 to 65 years.
The Pearson x 2 test, or the Fisher exact test, when necessary, was used to evaluate the differences of discrete characteristics between HCWs and members of the general population with acute HBV or HCV infection. P values less than .05 were considered statistically significant. All the statistical procedures were performed using Stata statistical software, version 8.1 (Stata).
results
During 1995-2004, a total of 87 acute hepatitis B cases and 67 acute hepatitis C cases were observed among HCWs. The incidence rate of acute HBV infection in both the general population and among HCWs declined during the study period; no significant difference was observed in the incidence of infection when the 2 groups were compared (Table 1) . In contrast, in nearly all years the incidence rate of acute HCV infection was significantly higher among HCWs, compared with the general population, peaking in 2001 (relative risk, 3.4 [95% confidence interval, 1.7-3.8]) ( Table 2) . No difference was found in the mean age or the sex ratio in the 2 groups. The proportion of acute hepatitis B patients with jaundice was approximately the same in the general population (86.3%) and among HCWs (84.3%); the proportion of acute hepatitis C patients with jaundice was higher in the general population, compared with HCWs (62.2% vs 54.8%); however, the difference did not reach a statistically significant level ( ) (data not shown).
The proportion of HCWs with acute HBV infection who had completed the hepatitis B vaccination schedule was 6.0% (5 cases); the median interval between the third dose administered and acute hepatitis B onset was 6.4 years (range, 1.7-13.2 years). Information on anti-HBV surface antigen titer after the end of the vaccination schedule was not available. Three other patients had started but not completed the vaccination schedule (1 patient received 1 dose and 2 patients received 2 doses).
Needlestick exposure was reported by 4.9% of HCWs with acute hepatitis B and 14.3% of HCWs with acute hepatitis C. Corresponding figures among the general population were significantly lower (0.1% and 0.2%, respectively; ) P ! .01 (data not shown).
discussion
The 57% of the Italian population covered by SEIEVA live in all regions of Italy, both urban and rural, and are treated in both referral and peripheral hospitals. Therefore, our study population is representative of the whole country. Moreover, the notification system was unchanged throughout the study period.
More importantly, the ascertainment of hepatitis has not been different or better for HCWs than for the general population, because hepatitis cases in both groups are identified through the same surveillance system and are therefore exposed to similar selective factors, if any. However, ascertainment bias is still possible. In fact, HCWs may be more likely to be diagnosed as having acute hepatitis (which is mostly asymptomatic) because they are regularly surveyed after an unintentional needlestick exposure. Because the proportion of individuals with jaundice (who are more easily ascertained) is similar in both groups for hepatitis B but slightly higher in the general population for hepatitis C, we may suppose that the excess of hepatitis C cases without jaundice among HCWs was diagnosed through regular surveillance after an unintentional exposure. After exclusion of individuals with asymptomatic acute HCV infection from the analysis, the estimated relative risks did not substantially change, suggesting that the observed findings are valid.
In contrast to the previous report from Italy, 1 the incidence of HBV infection among HCWs is no longer higher than in the general population, presumably reflecting better vaccination coverage in this population. Unfortunately, current nationwide figures for vaccination coverage against HBV among HCWs in Italy are not available. A survey performed in 1997 involving 3,175 HCWs in Italy showed hepatitis B vaccination coverage of 64.5% 2 ; HBV infection was more frequent among individuals with 5 or fewer years of employment, reflecting the introduction in 1989 of the recombinant vaccine. Concern about the theoretical risk of human immunodeficiency virus contamination from the formerly used plasma-derived vaccine was shown to be a contributory factor to low vaccine acceptance. 9 Indeed, during the 1990s, hepatitis B vaccination coverage among HCWs may have progressively increased because of the use of the recombinant vaccine. Moreover, because hepatitis B vaccination has been required by law in Italy since 1991 for all 12-year-olds, 10 the younger generations of HCWs were likely vaccinated against HBV during adolescence.
In contrast, the incidence of acute HCV infection was significantly higher in HCWs than in the general population, confirming the trend previously observed during 1991-1994.
The present findings agree with previous cohort studies that have shown a small but measurably increased risk for HCWs of acquiring HCV infection as a result of occupational exposure. [11] [12] [13] [14] In the absence of effective immunoprophylaxis measures against HCV infection, strict adherence to universal precautions for exposure to blood and other body fluids and attention to the correct disposal and handling of sharp objects in the hospital setting should be strongly recommended.
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